Braun Stacey Associates’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-95,661
Closed -$16.2M 126
2024
Q1
$16.2M Buy
95,661
+4,070
+4% +$762K 0.64% 72
2023
Q4
$18.1M Buy
91,591
+5,680
+7% +$1.01M 0.81% 56
2023
Q3
$14.9M Buy
85,911
+27,253
+46% +$4.95M 0.73% 62
2023
Q2
$10.1M Buy
58,658
+41,528
+242% +$7.18M 0.47% 88
2023
Q1
$2.85M Buy
17,130
+4,555
+36% +$747K 0.07% 109
2022
Q4
$1.84M Sell
12,575
-47,948
-79% -$7.1M 0.11% 105
2022
Q3
$8.97M Sell
60,523
-9,600
-14% -$1.6M 0.55% 85
2022
Q2
$12.1M Sell
70,123
-38,063
-35% -$6.58M 0.69% 72
2022
Q1
$20.4M Sell
108,186
-12,402
-10% -$2.45M 0.85% 50
2021
Q4
$29.4M Sell
120,588
-1,763
-1% -$386K 1.07% 23
2021
Q3
$23.8M Sell
122,351
-2,913
-2% -$588K 0.95% 31
2021
Q2
$23.3M Sell
125,264
-414
-0.3% -$71.9K 0.91% 40
2021
Q1
$19.8M Sell
125,678
-3,833
-3% -$607K 0.83% 53
2020
Q4
$21.4M Buy
129,511
+2,392
+2% +$389K 0.96% 32
2020
Q3
$21M Sell
127,119
-1,798
-1% -$276K 1.12% 17
2020
Q2
$17.7M Buy
128,917
+4,213
+3% +$550K 1.02% 30
2020
Q1
$14.7M Sell
124,704
-9,488
-7% -$1.25M 1.12% 28
2019
Q4
$17.8M Sell
134,192
-48,464
-27% -$6.02M 0.99% 39
2019
Q3
$22.8M Buy
182,656
+4,223
+2% +$510K 1.44% 9
2019
Q2
$20.3M Sell
178,433
-2,547
-1% -$267K 1.3% 12
2019
Q1
$18.2M Buy
180,980
+170
+0.1% +$15.4K 1.21% 19
2018
Q4
$15.5M Sell
180,810
-7,316
-4% -$659K 1.23% 18
2018
Q3
$17.2M Sell
188,126
-11,735
-6% -$1.04M 1.1% 29
2018
Q2
$17M Sell
199,861
-18,589
-9% -$1.57M 1.16% 24
2018
Q1
$18.2M Sell
218,450
-10,120
-4% -$797K 1.25% 13
2017
Q4
$16.5M Buy
228,570
+2,790
+1% +$192K 1.1% 30
2017
Q3
$14.4M Sell
225,780
-16,525
-7% -$1.04M 0.98% 45
2017
Q2
$15.1M Buy
242,305
+12,470
+5% +$736K 0.98% 47
2017
Q1
$12.3M Buy
+229,835
New +$12.4M 0.78% 70

Other funds holding ZTS

Braun Stacey Associates's ZTS Position: Q2 2024 in Review

Braun Stacey Associates sold out of Zoetis (ZTS) in Q2 2024, closing a stake of 95,661 shares — an estimated $16.2M sold.

Braun Stacey Associates first reported a position in ZTS in Q1 2017 and held it in 29 quarters. The position peaked at $29.4M in Q4 2021. 1,734 funds tracked by Wall St. Rank hold ZTS as of Q2 2024.

  • Braun Stacey Associates reported no remaining Zoetis position as of Q2 2024 after selling out during the quarter.
  • Braun Stacey Associates sold 95,661 Zoetis shares in Q2 2024, an estimated $16.2M.
  • Braun Stacey Associates first reported a position in Zoetis in Q1 2017 and held it in 29 quarters.
  • Braun Stacey Associates's Zoetis position peaked at $29.4M in Q4 2021.
  • 1,734 funds tracked by Wall St. Rank held Zoetis as of Q2 2024.

Based on Braun Stacey Associates's 13F filing for Q2 2024, filed 29 Jul 2024.